The aim of this article is to provide an overview of the European regulatory environment and to outline some of the main pharmaceutical regulations and requirements for companies to consider when bringing a new medicinal product to the European market. Graham Donaldson, Regulatory Affairs Project Manager for TRAC Services, explains.
https://international-pharma.com/wp-content/uploads/2015/06/Obtaining…pdf.pdf